Dr. Reddy’s Q1 net plunges 69% to ₹435.6 cr on lower revenue
Lower sales of cancer drug lenalidomide and ₹239.7 crore provision post recent quality issue around Semaglutide impact revenue of generic drugmaker
· 7/22/2026, 2:16:14 PM· 2 min read
Lower sales of cancer drug lenalidomide and ₹239.7 crore provision post recent quality issue around Semaglutide impact revenue of generic drugmaker
Read original story →Related stories
business
Cipla Q1 net dips 39% to ₹785.55 crore as North America business drags
business
Sebi mulls overhaul of online dispute resolution framework; seeks public comments till August 13
business
Maruti Suzuki’s New Brezza receives 5-star Bharat NCAP safety rating
business